David Dingli

30.9k citations

465 papers · 14.8k · 3 hit papers · h-index 64

Impact in

Hematology top 0.02%
- Multiple Myeloma Research and Treatments
Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Virus-based gene therapy research
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 297
- Multiple Myeloma Research and Treatments 218
- Chronic Myeloid Leukemia Treatments 54
Molecular Biology 223
- Amyloidosis: Diagnosis, Treatment, Outcomes 116
- Protein Degradation and Inhibitors 65

Co-authors: Morie A. Gertz (251 shared papers)Angela Dispenzieri (251 shared papers)Martha Q. Lacy (251 shared papers)Shaji Kumar (251 shared papers)Francis K. Buadi (251 shared papers)Stephen J. Russell (105 shared papers)Suzanne R. Hayman (243 shared papers)S. Vincent Rajkumar (196 shared papers)
Journals: Blood (109 papers)Journal of Clinical Oncology (43 papers)American Journal of Hematology (33 papers)Bone Marrow Transplantation (30 papers)Blood Cancer Journal (19 papers)
Partner nations: United States Portugal Germany

In The Last Decade

David Dingli

439 papers receiving 14.5k citations

David Dingli's Hit Papers

align trajectories log scale

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients 2013 · 957 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Leukemia
2012 Journal of Clinical Oncology
2007 Blood

Peers

Countries citing papers authored by David Dingli

Since Specialization

Citations

This map shows the geographic impact of David Dingli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Dingli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Dingli more than expected).

Fields of papers citing papers by David Dingli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Dingli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Dingli. The network helps show where David Dingli may publish in the future.

Co-authors

The 25 scholars most cited alongside David Dingli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Dingli Line = papers co-authored together David Dingli links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 465 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Improved survival in multiple myeloma and the impact of novel therapies Blood ·Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Steven R. Zeldenrust, David Dingli, Stephen J. Russell, John A. Lust, Philip R. Greipp, Robert A. Kyle, Morie A. Gertz Hit paper breakdown →	2007	1682
2	Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Leukemia ·Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Shivlal Pandey, Prashant Kapoor, David Dingli, Suzanne R. Hayman, Nelson Leung, John A. Lust, Arleigh McCurdy, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, S. Vincent Rajkumar Hit paper breakdown →	2013	957
3	Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements Journal of Clinical Oncology ·Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Colin Colby, Kristina Laumann, Steve R. Zeldenrust, Nelson Leung, David Dingli, Philip R. Greipp, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz Hit paper breakdown →	2012	730
4	Genetic Progression and the Waiting Time to Cancer PLoS Computational Biology ·Niko Beerenwinkel, Tibor Antal, David Dingli, Arne Traulsen, Kenneth W. Kinzler, Victor E. Velculescu, Bert Vogelstein, Martin A. Nowak	2007	288
5	Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter Blood ·David Dingli, Kah-Whye Peng, Mary Harvey, Philip R. Greipp, Michael K. O’Connor, Roberto Cattaneo, John C. Morris, Stephen J. Russell	2003	271
6	Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma Journal of Clinical Oncology ·Martha Q. Lacy, Suzanne R. Hayman, Morie A. Gertz, Angela Dispenzieri, Francis K. Buadi, Shaji Kumar, Philip R. Greipp, John A. Lust, Stephen J. Russell, David Dingli, Robert A. Kyle, Rafaël Fonseca, P. Leif Bergsagel, Vivek Roy, Joseph Mıkhael, A. Keith Stewart, Kristina Laumann, Jacob B. Allred, Sumithra J. Mandrekar, S. Vincent Rajkumar	2009	226
7	Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy Mayo Clinic Proceedings ·Stephen J. Russell, Mark J. Federspiel, Kah-Whye Peng, Caili Tong, David Dingli, William G. Morice, Val J. Lowe, Michael K. O’Connor, Robert A. Kyle, Nelson Leung, Francis K. Buadi, S. Vincent Rajkumar, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri	2014	220
8	Successful Therapy Must Eradicate Cancer Stem Cells Stem Cells ·David Dingli, Franziska Michor	2006	191
9	Circulating plasma cells detected by flow cytometry as a predictor of survival in 302 patients with newly diagnosed multiple myeloma Blood ·Grzegorz S. Nowakowski, Thomas E. Witzig, David Dingli, Michał Tracz, Morie A. Gertz, Martha Q. Lacy, John A. Lust, Angela Dispenzieri, Philip R. Greipp, Robert A. Kyle, S. Vincent Rajkumar	2005	177
10	Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics Blood ·Shaji Kumar, Rafaël Fonseca, Rhett P. Ketterling, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Ryan A. Knudson, Alexandra J. Greenberg, Stephen J. Russell, Steven R. Zeldenrust, John A. Lust, Robert A. Kyle, Leif Bergsagel, S. Vincent Rajkumar	2012	170
11	Systemic amyloidosis from A (AA) to T (ATTR): a review Journal of Internal Medicine ·Eli Muchtar, Angela Dispenzieri, Hila Magen, Martha Grogan, Michelle L. Mauermann, Ellen D. McPhail, Paul J. Kurtin, Nelson Leung, Francis K. Buadi, David Dingli, Shaji Kumar, Morie A. Gertz	2020	162
12	The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome Blood ·Anita D’Souza, Suzanne R. Hayman, Francis K. Buadi, Michelle L. Mauermann, Martha Q. Lacy, Morie A. Gertz, Robert A. Kyle, Shaji Kumar, Philip R. Greipp, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust, David Dingli, Thomas E. Witzig, S. Vincent Rajkumar, Angela Dispenzieri	2011	149
13	Coexistent Multiple Myeloma or Increased Bone Marrow Plasma Cells Define Equally High-Risk Populations in Patients With Immunoglobulin Light Chain Amyloidosis Journal of Clinical Oncology ·Taxiarchis Kourelis, Shaji Kumar, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, Nelson Leung, Robert A. Kyle, Stephen J. Russell, David Dingli, John A. Lust, Yi Lin, Prashant Kapoor, S. Vincent Rajkumar, Arleigh McCurdy, Angela Dispenzieri	2013	148
14	A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy Leukemia ·A. Keith Stewart, P. Leif Bergsagel, Philip R. Greipp, Angela Dispenzieri, Morie A. Gertz, Suzanne R. Hayman, Shaji Kumar, Martha Q. Lacy, John A. Lust, Stephen J. Russell, Thomas E. Witzig, Steven R. Zeldenrust, David Dingli, Craig B. Reeder, Vivek Roy, Robert A. Kyle, S. Vincent Rajkumar, Rafaël Fonseca	2007	136
15	Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis Bone Marrow Transplantation ·Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Shaji Kumar, David Dingli, Nelson Leung, William J. Hogan, Francis K. Buadi, Suzanne R. Hayman	2012	130
16	Recent Improvements in Survival in Primary Systemic Amyloidosis and the Importance of an Early Mortality Risk Score Mayo Clinic Proceedings ·Shaji Kumar, Morie A. Gertz, Martha Q. Lacy, David Dingli, Suzanne R. Hayman, Francis K. Buadi, Kristen Short-Detweiler, Steven R. Zeldenrust, Nelson Leung, Philip R. Greipp, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Angela Dispenzieri	2010	124
17	Modeling of cancer virotherapy with recombinant measles viruses Journal of Theoretical Biology ·Željko Bajzer, Thomas J. Carr, Krešimir Josić́, Stephen J. Russell, David Dingli	2008	123
18	Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myeloma Leukemia ·Angela Dispenzieri, Chin Voon Tong, Betsy LaPlant, M. Q. Lacy, Kristina Laumann, David Dingli, Yumei Zhou, Mark J. Federspiel, Morie A. Gertz, S. R. Hayman, Francis K. Buadi, Michael K. O’Connor, Val J. Lowe, K-W Peng, Stephen J. Russell	2017	121
19	Importance of Achieving Stringent Complete Response After Autologous Stem-Cell Transplantation in Multiple Myeloma Journal of Clinical Oncology ·Prashant Kapoor, Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Stephen J. Russell, Suzanne R. Hayman, Thomas E. Witzig, John A. Lust, Nelson Leung, Yi Lin, Steven R. Zeldenrust, Arleigh McCurdy, Philip R. Greipp, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz	2013	120
20	Unexplained Pulmonary Hypertension in Chronic Myeloproliferative Disorders CHEST Journal ·David Dingli, James P. Utz, Michael J. Krowka, Ann L. Oberg, Ayalew Tefferi	2001	118

About David Dingli

David Dingli is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Epidemiology, having authored 465 papers that have together received 14.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (218 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (116 papers), Protein Degradation and Inhibitors (65 papers), Chronic Myeloid Leukemia Treatments (54 papers), Cancer Treatment and Pharmacology (52 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (51 papers), Peptidase Inhibition and Analysis (50 papers) and Chronic Lymphocytic Leukemia Research (41 papers). The work is most often cited by research in Hematology (8.0k citations), Genetics (2.7k citations), Oncology (5.3k citations), Nephrology (964 citations) and Molecular Biology (8.9k citations). David Dingli has collaborated with scholars based in United States, Portugal and Germany. Frequent co-authors include Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Shaji Kumar, Francis K. Buadi, Stephen J. Russell, Suzanne R. Hayman, S. Vincent Rajkumar, Robert A. Kyle and John A. Lust. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Bone Marrow Transplantation and Blood Cancer Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

David Dingli

Impact in

Papers in i

In The Last Decade

David Dingli

David Dingli's Hit Papers

Peers

Countries citing papers authored by David Dingli

Fields of papers citing papers by David Dingli

All Works

About David Dingli

Explore authors with similar magnitude of impact

Papers in